Applied Biosciences Corp.
APPB
Rank in Stocks
#34945
Applied Biosciences Corp. is dedicated to the creation and market launch of... Applied Biosciences Corp. is dedicated to the creation and market launch of synthetic cannabinoid biopharmaceutical treatments. These advanced therapeutics are specifically designed to interact with the body's endocannabinoid system, aiming to address a wide array of diseases across diverse medical specialties. Furthermore, the company offers over-the-counter, THC-free CBD products directly to consumers, which are intended to support general health and well-being. It also provides specialized testing and analytical services to its customers. The firm was founded in 2014 and operates from its base in Beverly Hills, California.
Share Price
$0.0001
Last synced: 2026-11-06
Market Cap
$2.20K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Applied Biosciences Corp. (APPB)
Category
Healthcare
Operating Margin for Applied Biosciences Corp. (APPB)
Operating Margin as of November 2026 TTM: -781.32%
According to Applied Biosciences Corp.'s latest financial reports, its current operating margin (TTM) is -781.32%. At the end of 2021 the company had an operating margin of -781.32%.
Operating Margin history for Applied Biosciences Corp. from 2014 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -781.32% | 0.00% |
| 2021 | -781.32% | 82.92% |
| 2020 | -427.13% | 14.12% |
| 2019 | -374.27% | 23.33% |
| 2018 | -303.48% | -73.20% |
| 2017 | -1,132.55% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -100.02% |
DE
|
|
| 19.68% | -100.03% |
DE
|
|
| 13.26% | -100.02% |
JP
|
|
| 17.08% | -100.02% |
CH
|
|
| 14.92% | -100.02% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Applied Biosciences Corp.'s operating margin
What is Applied Biosciences Corp.'s operating margin?
Applied Biosciences Corp.'s operating margin is -781.32%, as of Nov 2026.
What was Applied Biosciences Corp.'s operating margin in 2021?
In 2021, Applied Biosciences Corp.'s operating margin was -781.32%, compared with -427.13% in 2020.
How has Applied Biosciences Corp.'s operating margin changed since 2016?
From 2016 to 2021, Applied Biosciences Corp.'s operating margin was highest in 2016 (0.00%) and lowest in 2017 (-1,132.55%).
How does Applied Biosciences Corp.'s operating margin compare with similar companies?
Applied Biosciences Corp.'s operating margin (-781.32%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.